IL164088A0 - Human deubiquitinating protease gene on chromosome7 and its murineortholog - Google Patents
Human deubiquitinating protease gene on chromosome7 and its murineorthologInfo
- Publication number
- IL164088A0 IL164088A0 IL16408803A IL16408803A IL164088A0 IL 164088 A0 IL164088 A0 IL 164088A0 IL 16408803 A IL16408803 A IL 16408803A IL 16408803 A IL16408803 A IL 16408803A IL 164088 A0 IL164088 A0 IL 164088A0
- Authority
- IL
- Israel
- Prior art keywords
- murineortholog
- protease gene
- deubiquitinating protease
- human deubiquitinating
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Plant Pathology (AREA)
- Pain & Pain Management (AREA)
- Analytical Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36660102P | 2002-03-22 | 2002-03-22 | |
GBGB0218518.9A GB0218518D0 (en) | 2002-03-22 | 2002-08-09 | Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
PCT/US2003/008590 WO2003083050A2 (fr) | 2002-03-22 | 2003-03-21 | Gene humain de la protease de desubiquitination positionnee sur le chromosome 7 et son orthologue murin |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164088A0 true IL164088A0 (en) | 2005-12-18 |
Family
ID=28676509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16408803A IL164088A0 (en) | 2002-03-22 | 2003-03-21 | Human deubiquitinating protease gene on chromosome7 and its murineortholog |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1495117A4 (fr) |
JP (1) | JP2005520567A (fr) |
AU (1) | AU2003230701C1 (fr) |
BR (1) | BR0307759A (fr) |
CA (1) | CA2479647A1 (fr) |
IL (1) | IL164088A0 (fr) |
MX (1) | MXPA04006975A (fr) |
WO (1) | WO2003083050A2 (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2229204C (fr) * | 1995-08-09 | 2012-10-09 | Alan D. D'andrea | Enzymes de desubiquitination regulant la croissance des cellules |
CA2374745A1 (fr) * | 1999-08-09 | 2001-02-15 | Incyte Genomics, Inc. | Proteases et inhibiteurs de proteases |
WO2001023589A2 (fr) * | 1999-09-29 | 2001-04-05 | Millennium Pharmaceuticals, Inc. | Nouvelle ubiquitine protease humaine nommee 23431 |
-
2003
- 2003-03-21 MX MXPA04006975A patent/MXPA04006975A/es active IP Right Grant
- 2003-03-21 JP JP2003580486A patent/JP2005520567A/ja active Pending
- 2003-03-21 AU AU2003230701A patent/AU2003230701C1/en not_active Ceased
- 2003-03-21 IL IL16408803A patent/IL164088A0/xx unknown
- 2003-03-21 EP EP03723791A patent/EP1495117A4/fr not_active Withdrawn
- 2003-03-21 BR BR0307759-4A patent/BR0307759A/pt not_active Application Discontinuation
- 2003-03-21 WO PCT/US2003/008590 patent/WO2003083050A2/fr not_active Application Discontinuation
- 2003-03-21 CA CA002479647A patent/CA2479647A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003083050A3 (fr) | 2004-02-26 |
EP1495117A4 (fr) | 2005-06-08 |
JP2005520567A (ja) | 2005-07-14 |
EP1495117A2 (fr) | 2005-01-12 |
AU2003230701C1 (en) | 2009-08-27 |
CA2479647A1 (fr) | 2003-10-09 |
WO2003083050A2 (fr) | 2003-10-09 |
BR0307759A (pt) | 2004-12-21 |
MXPA04006975A (es) | 2004-11-10 |
AU2003230701A1 (en) | 2003-10-13 |
AU2003230701B2 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1539941A4 (fr) | Adzymes et leurs utilisations | |
EG25097A (en) | Piprazinyl and diazapanyl benzamides and benzthioamides. | |
IL166377A0 (en) | Vrgfr-2 and vgefr-3 inhibitory and anthranylamidpyrimidines | |
EP1466982A4 (fr) | Pyroglutamyle peptidase et gene correspondant | |
EP1652855A4 (fr) | Polypeptides agissant sur des predispositions a des pathologies cerebrales et utilisation desdits polypeptides | |
PL375355A1 (en) | Novel lipases and uses thereof | |
AU2003215052A8 (en) | Proteolytic fermenter | |
GB2408530B (en) | Well completion systems and methods | |
AU2003280084A8 (en) | Protein arrays and uses thereof | |
IL165112A0 (en) | Variant integrinpolypeptides and thereof | |
EP1496122A4 (fr) | Gene resistant au genre meloidogyne, et utilisation | |
AU2003231827A1 (en) | Pseudo-tissues and uses thereof | |
TWI348914B (en) | Human deubiquitinating protease gene on chromosome 7 and its murine ortholog | |
AU2003302173A8 (en) | Spirotetrathiocarbamates and spirooxothiocarbamates | |
AU2003262744A8 (en) | Alpha-amylase assay and uses thereof | |
EP1644476A4 (fr) | Nouvelle phytase et gene correspondant | |
IL164088A0 (en) | Human deubiquitinating protease gene on chromosome7 and its murineortholog | |
AU2003300859A8 (en) | Carrier-ligand fusions and uses thereof | |
EP1589101A4 (fr) | Nouvelle proteine et son gene | |
AU2003228397A8 (en) | Hausp-p53 interaction and uses thereof | |
EP1577322A4 (fr) | Nouvelles proteines et leur utilisation | |
EP1541677A4 (fr) | Nouvelles proteines et leur utilisation | |
GB0207624D0 (en) | Chemokine and uses thereof | |
AU2003216442A8 (en) | Enkurin and uses thereof | |
EP1699809A4 (fr) | Peptide provenant du liquide amniotique et ses utilisations |